[go: up one dir, main page]

Lima et al., 2008 - Google Patents

Principles of Organ Preservation

Lima et al., 2008

Document ID
4069458763245956127
Author
Lima B
Tuttle-Newhall J
Publication year
Publication venue
Surgery: Basic Science and Clinical Evidence

External Links

Snippet

Organ preservation refers to the maintenance of ex vivo organ viability and restoration of normal organ function when physiologic blood flow is reestablished. 1 This paradigm defines the basis for current clinical and research models of organ transplantation. If an …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
    • A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Clavien et al. Preservation and reperfusion injuries in liver allografts
Serracino-Inglott et al. Hepatic ischemia-reperfusion injury
Vajdová et al. ATP‐supplies in the cold‐preserved liver: A long‐neglected factor of organ viability
Taylor Biology of cell survival in the cold: the basis for biopreservation of tissues and organs
Monden et al. Twenty-four-and 48-hour canine liver preservation by simple hypothermia with prostacyclin
Wicomb et al. Orthotopic transplantation of the baboon heart after 20 to 24 hours’ preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution
FR2625073A1 (en) INFUSION FLUID FOR ORGAN CONSERVATION
de Rougemont et al. Biological modulation of liver ischemia–reperfusion injury
Schauer et al. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation
Schauer et al. MICROCIRCULATORY FAILURE AFTER RAT LIVER TRANSPLANTATION IS RELATED TO KUPFFER CELL-DERIVED OXIDANT STRESS BUT NOT INVOLVED IN EARLY GRAFT DYSFUNCTION1
Monbaliu et al. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non–heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity
Hashimoto et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1
Ishizaki et al. COMPARISON OF VARIOUS LAZAROID COMPOUNDS FOR PROTECTION AGAINST ISCHEMIC LIVER INJURY1, 2
Bezinover et al. Use of a third-generation perfluorocarbon for preservation of rat DCD liver grafts
Jacobs et al. Current preservation technology and future prospects of thoracic organs. Part 2: heart
LEMASTERS et al. Dual role of Kupffer cell activation and endothelial cell damage in reperfusion injury to livers stored for transplantation surgery
Smulowitz et al. Ex vivo cardiac allograft preservation by continuous perfusion techniques
Schemmer et al. New aspects on reperfusion injury to liver—impact of organ harvest.
Nydegger et al. New concepts in organ preservation
Lima et al. Principles of Organ Preservation
Serrick et al. Amelioration of pulmonary allograft injury by administering a second rinse solution
Yamamoto et al. A leukocyte depleting filter reduces endothelial cell dysfunction and improves transplanted canine heart function
Bukberg et al. Results following hypothermic asanguineous liver perfusion in dogs
Wilson et al. Preservation solutions for solid organ transplantation
Astarcoglu et al. Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats